Page 9 - Ace2 News Today

New research details the molecular landscape of Omicron’s RBD and how it differs from the original SARS-CoV-2 strain.

A new study shows that the ACE2 and RBD of coronavirus spike fragments have different binding strengths and dissociation rates when they are glycosylated and non-glycosylated.

A new study discusses the effect of the Omicron variant’s mutations on its binding efficiency to the ACE2 receptor.

A recent study tested the RBD of 2 sarbecoviruses found in Russian horseshoe bats and other clades 3 viruses for their ability to invade the human cell.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), since its emergence, has continuously evolved to evade host hostilities as well as increase transmission by raising new variants of...

New study results provide evidence that the binding between SARS-CoV-2 RBD and host ACE2 receptor is aided by the glycosylation on each protein.

Scientists attempt to understand the evolution of the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2.

Researchers from Universite Grenoble Alpes have been investigating the changes in the Omicron variant RBD and how they affect ACE2 binding.

Researchers from the Management and Science University in Malaysia have used computational tools to investigate the new variant.

According to a group of Italian and American researchers led by Fabrizio dAdda di Fagagna, the expression of the cell receptor for the SARS-CoV-2 virus, ACE2 which is essential for mediating cell entry of the virus, increases in the lungs of ageing mice and humans. Damaged Telomeres in Elders Might Increase Susceptibility to SARS-CoV-2 Virus, Says Study.